Literature DB >> 7059461

Response of two mouse tumours to hyperthermia with CCNU or melphalan.

M C Joiner, G G Steel, T C Stephens.   

Abstract

The in vivo response of B16 melanoma and Lewis lung carcinoma to combinations of hyperthermia and graded doses of CCNU or Melphalan was studied. To obtain dose-response curves and quantitative comparisons of different treatments, an agar-colony assay was used to measure survival of cells from excised tumours. For heating experiments, the use of 2 tumours per animal, one heated and one not, allowed all other factors to be kept constant. When tumours were immersed in a water-bath at 43 degrees C for 1 h, Thermal Enhancement Ratios (TER) measured from the slopes of the dose-response curves were up to 1.6 for CCNU and 2.4 for Melphalan. Direct heat killing of about 1 decade was seen for 1 h at 43 degrees C. The anaesthetic Saffan also enhanced drug cell kill; the largest Dose Modifying Factor (2.7) was measured for Melphalan in the Lewis lung tumour. The duration of heating, and waterbath temperature, both influenced the enhancement of cell killing by CCNU, as did the time of excision of tumours between 0 and 3 1/2 h after treatment. There was no difference in effect between 3 1/2 and 24 h. The interaction between heat and CCNU varied if the interval between them was altered. The maximum effect was found if the heat and drug were given in close sequence.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059461      PMCID: PMC2010966          DOI: 10.1038/bjc.1982.3

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Stem-cell survival and tumor control in the Lewis lung carcinoma.

Authors:  G G Steel; K Adams
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

2.  Thermal enhancement of thio-TEPA cytotoxicity.

Authors:  H A Johnson; M Pavelec
Journal:  J Natl Cancer Inst       Date:  1973-04       Impact factor: 13.506

3.  Thermometry considerations in localized hyperthermia.

Authors:  T C Cetas; W G Connor
Journal:  Med Phys       Date:  1978 Mar-Apr       Impact factor: 4.071

4.  Good thermal dosimetry is essential to good hyperthermia research.

Authors:  J E Robinson; G H Harrison; W A McCready; G M Samaras
Journal:  Br J Radiol       Date:  1978-07       Impact factor: 3.039

5.  Influence of anaesthetics on tumour-cell kill and repopulation in B16 melanoma treated with melphalan.

Authors:  J H Peacock; T C Stephens
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

6.  Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

Authors:  T C Stephens; J H Peacock
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

7.  A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse.

Authors:  V D Courtenay
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

8.  Interaction of hyperthermia and the hypoxic cell sensitizer Ro-07-0582 on the EMT6 mouse tumour.

Authors:  N M Bleehen; D J Honess; J E Morgan
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

9.  Cell yield and cell survival following chemotherapy of the B16 melanoma.

Authors:  T C Stephens; J H Peacock
Journal:  Br J Cancer       Date:  1978-11       Impact factor: 7.640

10.  Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors.

Authors:  T C Stephens; G A Currie; J H Peacock
Journal:  Br J Cancer       Date:  1978-11       Impact factor: 7.640

View more
  6 in total

1.  Synergistic effect of K-18 and concomitant hyperthermia for treatment of Lewis lung carcinoma in mice.

Authors:  R Tamada; H Kai; K Sugimachi; K Takenaka; Y Hiramoto; K Inokuchi
Journal:  Jpn J Surg       Date:  1985-03

2.  Enhanced antitumor efficacy with a combination of hyperthermochemotherapy and thermosensitization with polyamine antimetabolites in nude mice.

Authors:  S Fujimoto; R D Shrestha; M Ohta; K Igarashi; F Endoh; M Kokubun; S Koike; Y Togawa; K Okui
Journal:  Jpn J Surg       Date:  1987-03

3.  Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies.

Authors:  James F Pingpank; Steven K Libutti; Richard Chang; Bradford J Wood; Ziv Neeman; Anthony W Kam; William D Figg; Souping Zhai; Tatiana Beresneva; Geoffrey D Seidel; H Richard Alexander
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

4.  Miniature microwave applicator for murine bladder hyperthermia studies.

Authors:  Sara Salahi; Paolo F Maccarini; Dario B Rodrigues; Wiguins Etienne; Chelsea D Landon; Brant A Inman; Mark W Dewhirst; Paul R Stauffer
Journal:  Int J Hyperthermia       Date:  2012-06-12       Impact factor: 3.914

5.  The effectiveness of cis-platinum, cyclophosphamide and melphalan in treating disseminated tumor cells in mice.

Authors:  A Kanclerz; J D Chapman
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

Review 6.  Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all.

Authors:  Arlene L Oei; Lianne E M Vriend; Johannes Crezee; Nicolaas A P Franken; Przemek M Krawczyk
Journal:  Radiat Oncol       Date:  2015-08-07       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.